HS387
/ Zhejiang Hisun Pharmaceutical
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
July 31, 2025
A Phase Ia/ Ib Study of HS387 in Subjects With Advanced Solid Tumors
(clinicaltrials.gov)
- P1 | N=110 | Recruiting | Sponsor: Zhejiang Hisun Pharmaceutical Co. Ltd.
New P1 trial • Oncology • Solid Tumor
1 to 1
Of
1
Go to page
1